J. M. Llovet, J. Zucman-rossi, E. Pikarsky, B. Sangro, M. Schwartz et al., Hepatocellular carcinoma, Nat Rev Dis Primers, vol.2, p.16018, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01910322

J. Calderaro, G. Couchy, S. Imbeaud, G. Amaddeo, E. Letouze et al., Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification, J Hepatol, vol.67, pp.727-738, 2017.

C. Guichard, G. Amaddeo, S. Imbeaud, Y. Ladeiro, L. Pelletier et al., Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma, Nat Genet, vol.44, pp.694-702, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00719917

Y. Hoshida, S. M. Nijman, M. Kobayashi, J. A. Chan, J. P. Brunet et al., Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma, Cancer Res, vol.69, pp.7385-92, 2009.

J. Zucman-rossi, A. Villanueva, J. C. Nault, and J. M. Llovet, Genetic landscape and biomarkers of hepatocellular carcinoma, Gastroenterology, vol.149, pp.1226-1265, 2015.

S. M. Ahn, S. J. Jang, J. H. Shim, D. Kim, S. M. Hong et al., A genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification, Hepatology, vol.60, pp.1972-82, 2014.

R. Macsween, A. D. Burt, B. Portmann, and L. D. Ferrell, MacSween's pathology of the liver, vol.6, p.online, 2011.

F. T. Bosman, World Health Organization, International Agency for Research on Cancer. WHO classification of tumours of the digestive system. Lyon: International Agency for Research on Cancer, p.417, 2010.

M. Ziol, N. Pote, G. Amaddeo, A. Laurent, J. C. Nault et al., Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance, Hepatology, vol.68, pp.103-115, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01744935

P. S. Tan, S. Nakagawa, N. Goossens, A. Venkatesh, T. Huang et al., Clinicopathological indices to predict hepatocellular carcinoma molecular classification, Liver Int, vol.36, pp.108-126, 2015.

, Electronic address wbe, Cancer Genome Atlas Research N. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma, Cell, vol.169, pp.1327-1368, 2017.

H. Li and R. Durbin, Fast and accurate short read alignment with Burrows-Wheeler transform, Bioinformatics, vol.25, pp.1754-60, 2009.

M. I. Love, W. Huber, and S. Anders, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol, vol.15, p.550, 2014.

M. E. Ritchie, B. Phipson, D. Wu, Y. Hu, C. W. Law et al., limma powers differential expression analyses for RNA-sequencing and microarray studies, Nucleic Acids Res, vol.43, p.47, 2015.

A. Subramanian, P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert et al., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci U S A, vol.102, pp.15545-50, 2005.

L. M. Mcshane, D. G. Altman, W. Sauerbrei, S. E. Taube, M. Gion et al., REporting recommendations for tumour MARKer prognostic studies (REMARK), Br J Cancer, vol.93, pp.387-91, 2005.

M. Ziol, A. Sutton, J. Calderaro, N. Barget, M. Aout et al., ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma, J Hepatology, vol.59, pp.1264-70, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02067507

G. W. Huang, Y. M. Tao, and X. Ding, Endocan expression correlated with poor survival in human hepatocellular carcinoma, Dig Dis Sci, vol.54, pp.389-94, 2009.

L. Y. Chen, X. Liu, S. L. Wang, and C. Y. Qin, Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion, J Intl Med Res, vol.38, pp.498-510, 2010.

D. Ribatti, A. Marzullo, A. Gentile, V. Longo, B. Nico et al., Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma, Histopathology, vol.50, pp.591-597, 2007.

G. Deli, C. H. Jin, R. Mu, S. Yang, Y. Liang et al., Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues, World J Gastroenterol, vol.11, pp.960-963, 2005.

D. Semela and J. F. Dufour, Angiogenesis and hepatocellular carcinoma, J Hepatol, vol.41, pp.864-80, 2004.

P. Swietach, R. D. Vaughan-jones, and A. L. Harris, Regulation of tumor pH and the role of carbonic anhydrase 9, Cancer Metastasis Rev, vol.26, pp.299-310, 2007.

F. Roudnicky, C. Poyet, P. Wild, S. Krampitz, F. Negrini et al., Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis, Cancer Res, vol.73, pp.1097-106, 2013.

E. Villa, R. Critelli, B. Lei, G. Marzocchi, C. Camma et al., Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study, Gut, vol.65, pp.861-870, 2016.

B. D. Grigoriu, F. Depontieu, A. Scherpereel, D. Gourcerol, P. Devos et al., Endocan expression and relationship with survival in human nonsmall cell lung cancer, Clin Cancer Res, vol.12, pp.4575-82, 2006.

C. A. Maurage, E. Adam, J. F. Mineo, S. Sarrazin, M. Debunne et al., Endocan expression and localization in human glioblastomas, J Neuropathol Exp Neurol, vol.68, pp.633-674, 2009.

L. C. Dieterich, S. Mellberg, E. Langenkamp, L. Zhang, A. Zieba et al., Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFbeta2 in vascular abnormalization, J Pathol, vol.228, pp.378-90, 2012.

X. Leroy, A. S. Zini, L. Franquet, H. Kervoaze, G. Villers et al., Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma, Histopathology, vol.56, pp.180-187, 2010.

N. Almog, L. Ma, R. Raychowdhury, C. Schwager, R. Erber et al., Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype, Cancer Res, vol.69, pp.836-880, 2009.

F. M. Recchia, L. Xu, J. S. Penn, B. Boone, and P. J. Dexheimer, Identification of genes and pathways involved in retinal neovascularization by microarray analysis of two animal models of retinal angiogenesis, Invest Ophthalmol Vis Sci, vol.51, pp.1098-105, 2010.

T. Holopainen, P. Saharinen, D. 'amico, G. Lampinen, A. Eklund et al., Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis, J Natl Cancer Inst, vol.104, pp.461-75, 2012.

M. Schmittnaegel, N. Rigamonti, E. Kadioglu, A. Cassara, C. Wyser-rmili et al., Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade, Clin Cancer Res Julien Calderaro, vol.9, pp.5859-5865, 2017.